AvePoint FY26 Sales Guidance Cut Below $512.73M Estimate
AvePoint cuts FY2026 sales guidance to $508.5M-$512.5M, missing the $512.73M estimate. The revised range is narrower than the prior $509.4M-$517.4M outlook, reflecting increased caution in revenue projections.

*this image is generated using AI for illustrative purposes only.
AvePoint (NASDAQ: AVPT) has reduced its sales guidance for fiscal year 2026, setting a new range of $508.5 million to $512.5 million. This adjustment represents a downward revision from its prior outlook of $509.4 million to $517.4 million. The revised ceiling of $512.5 million now sits below the market consensus estimate of $512.73 million, indicating that the company expects its top-line performance to fall short of analyst expectations for the full year.
The reduction in the guidance range narrows the total spread by approximately $4.9 million compared to the previous forecast. While the lower bound of the new guidance ($508.5 million) is slightly below the previous lower bound ($509.4 million), the most significant change is the contraction at the upper end, which drops by nearly $5 million. This shift suggests increased uncertainty or identified risks in AvePoint’s ability to capture the higher end of its previously projected revenue potential.
Guidance Revision Details
The following table outlines the changes in AvePoint’s fiscal year 2026 sales outlook:
| Metric | Previous Guidance | Revised Guidance | Market Estimate |
|---|---|---|---|
| Lower Bound | $509.4 million | $508.5 million | - |
| Upper Bound | $517.4 million | $512.5 million | - |
| Midpoint | $513.4 million | $510.5 million | - |
The market estimate of $512.73 million serves as a key benchmark for investor expectations. With the revised upper bound failing to meet this figure, AvePoint’s management is effectively acknowledging that achieving consensus estimates may not be feasible under current operating conditions.
What the Numbers Show
The narrowing of the guidance range from an $8 million spread to a $4 million spread indicates a more conservative and precise view of future performance. The fact that the entire revised range now overlaps significantly with the lower end of previous expectations suggests that AvePoint is prioritizing certainty over optimism. Investors should note that the revised midpoint of $510.5 million is also below the market estimate, reinforcing the negative signal regarding near-term revenue prospects.
What specific macroeconomic or industry-specific headwinds are driving AvePoint's decision to narrow its guidance range and lower its revenue ceiling?
How might this downward revision impact AvePoint's stock valuation multiples and investor sentiment in the near term?
Will AvePoint adjust its cost structure or operational expenses to protect profit margins given the reduced top-line outlook?



























